TechTalk: Revealing deeper ADC cytotoxicity insights with live cell analysis for drug discovery
Friday, March 20 at 15:00 GMT | 16:00 CET | 11:00 EDT | 08:00 PDT
Antibody-drug conjugates (ADCs) require precise, reliable in vitro assays to understand potency, kinetics, and mechanism of action early in development. Traditional endpoint assays often miss critical dynamic responses and introduce variability through dyes and labels.
In this 20‑minute SelectScience® TechTalk, Field Application Scientist Viswanath Lanka will demonstrate how the Maestro Z™ label‑free monitoring system enables real‑time, impedance‑based assessment of ADC‑mediated cytotoxicity. See how continuous kinetic data reveals differences in killing dynamics, accelerates detection, and supports confident potency quantification.
Register today to learn how to simplify your workflow, improve reproducibility, and apply practical examples of how Maestro Z supports confident decision-making in oncology drug discovery.
Key learning objectives:
- Understand why real-time, kinetic measurements are critical for accurately assessing ADC cytotoxicity
- Learn how label-free impedance assays can be faster and more sensitive than traditional endpoint methods
- Explore practical considerations for implementing real-time ADC assays in discovery workflows
Who should attend?
- Drug discovery, oncology, and ADC‑focused scientists across pharma, biotech, CROs, and academic labs working on targeted therapies, cytotoxicity, and phenotypic screening.
- Assay development, optimization, and cell‑based assay specialists, including lab managers and screening scientists running cytotoxicity, viability, and phenotypic workflows.
- Teams advancing antibody‑drug conjugates, oncology research, and next‑generation drug discovery, with a focus on stability, potency, and decision‑making in early development.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available
Speakers
Viswanath Lanka is a Field Application Scientist at Axion BioSystems, where he applies deep technical expertise in real‑time, label‑free impedance analysis and microelectrode array (MEA) electrophysiology to help researchers design rigorous functional assays across biology and drug discovery. At Axion, he has supported applications ranging from cytotoxicity and barrier integrity to complex phenotypic profiling, including impedance‑based assessment of HER2‑targeted antibody‑drug conjugates on the Maestro Z platform.
